Stock screener

MRVI

Conviction 100HealthcareScan · Thu, Jun 25, 2026
MRVI$6.12+6.25%
ResistanceSupportVol 14Insider sell
63 bars
Vol MA14 4.94M
Mar 26Apr 14May 1May 19Jun 8Jun 25
MARAVAI LIFESCIENCES HOLDINGS, INC.PHARMACEUTICAL PREPARATIONSwww.maravai.com
Price6.12
Change+6.25%
Gap+0.43%
Rel volume11.14×
Avg volume4.4M
Avg $ vol23.99M
SMA 205.11
SMA 504.43
SMA 2003.58
Price vs 50+38.14%
Price vs 200+71.14%
MA stackbullish
50/200 cross
Supertrendup · 5.13
RSI (14)83
MACD hist0.06
MACD crossbull · 1d
Stoch %K / %D93 / 94
ADX (14)48
+DI / −DI40 / 7
RSI divergence
MACD divergence
ATR %+4.57%
ADR %5.24%
52w high6.12
52w low2.03
From 52w high+0.00%
Above 52w low+202.22%
New 52w highYes
SqueezeOff
Bollinger width26.18%
%B1.26
Donchian pos94.57%
Donchian high6.22
Donchian low4.38
AVWAP (52w high)6.04
vs AVWAP high+1.30%
AVWAP (52w low)3.83
vs AVWAP low+59.67%
OBV trendUp
Chaikin MF (20)0.25
Today vs 20d11.14×
Avg vol (14d)4.94M
Avg vol (20d)4.4M
Avg $ vol (20d)23.99M
Market cap883.48M
RS 3m (vs SPY)+74.76%
RS 6m (vs SPY)+60.19%
RS line new highYes
Trend template8/8
Technical rank96.1
1 week+17.24%
1 month+39.73%
3 months+96.78%
6 months+74.86%
1 year+174.44%
YTD+80.00%
P/E-6.76
P/B4.18
P/S4.76
P/FCF-12.49
EPS-0.9000
Div yield
ROE-61.81%
ROA-18.34%
Debt/Eq1.14
Current5.91
EV/EBITDA
Gross margin18.30%
Net margin-70.41%
Rev growth-28.34%
EPS growth9.72%
Price target5.67
Target upside-7.35%
Analyst ratingBuy
Institutional89.78%
Ent. value958.57M
Revenue65.84M
Net income-3.73M
Gross profit33.7M
Free cash flow-70.72M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out147.51M
Employees416
ListedFri, Nov 20, 2020
Free float117.94M
Float %80.6%
Short interest7.87M
Days to cover3.0d
Short volume25.9%
Squeeze score43 / 100
Next earnings
EPS forecast
Last EPS vs est−$0.03 vs −$0.07
Last surprise+57.1% beat
Setup gradeA+
Conviction100 / 100
Pattern quality
Tech rank96.1 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction
Pattern family
Resistance5.26
Support3.87
Days since event
Candle confirm
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in MRVI

All disclosures →
No recent disclosed trades by Congress in MRVI. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in MRVI · 5 buys · 4 sells

InsiderSideShares
ORESHACK KURT
General Counsel · Class A Common Stock · 2026-06-10
Sell25K
ORESHACK KURT
General Counsel · Class A Common Stock · 2026-06-09
Sell25K
LUCIER GREGORY T
Director · Class A Common Stock · 2026-06-09
Gift46.29K
LUCIER GREGORY T
Director · Class A Common Stock · 2026-06-09
Gift46.29K
Brust Bernd
Chief Executive Officer · Class A Common Stock · 2026-06-08
Tax351K
Brust Bernd
Chief Executive Officer · Class A Common Stock · 2026-06-08
Other
ECKERT R ANDREW
Director · Class A Common Stock · 2026-05-26
Grant46.29K
MIHAS CONSTANTINE S
Director · Class A Common Stock · 2026-05-26
Grant46.29K
LUCIER GREGORY T
Director · Class A Common Stock · 2026-05-26
Grant46.29K
CUNNINGHAM SEAN LAURENCE
Director · Class A Common Stock · 2026-05-26
Grant46.29K

SEC filings

EDGAR filings in MRVI · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.